Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD63 Mouse anti-Human, Allophycocyanin/Cy7, Clone: MEM-259, Novus Biologicals™

Mouse Monoclonal Antibody

Manufacturer:  Novus Biologicals NB10077913APCCY7

Catalog No. N1077913AP7


Add to cart

Description

Description

CD63 Monoclonal antibody specifically detects CD63 in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

CD63
MEM-259
Flow Cytometry
Conjugated, Purified
CD63
HPB-ALL T cell line
Protein A purified
Autophagy, Cancer, Cardiovascular Biology, Cellular Signaling, Cytokine Research, Immunology, Innate Immunity, Lysosome Markers
Primary
967.0
Human
Flow Cytometry
APC-Cyanine7
PBS with 0.05% Sodium Azide
CD63 antigen, CD63 antigen (melanoma 1 antigen), CD63 molecule, Granulophysin, LAMP-3, Lysosomal-associated membrane protein 3, ME491, melanoma 1 antigen, Melanoma-associated antigen ME491, melanoma-associated antigen MLA1, MLA1lysosome-associated membrane glycoprotein 3, Ocular melanoma-associated antigen, OMA81H, Tetraspanin-30, tspan-30, TSPAN30granulophysin
Mouse
IgG1
0.1 mL
Store at 4°C in the dark. Do not freeze.
Monoclonal
The antibody MEM-259 reacts with CD63 (LAMP-3), a 40-60 kDa tetraspan glycoprotein expressed by granulocytes, platelets, T-cells, monocytes/macrophages and endothelial cells. Cell surface exposition of CD63 is usually activation-dependent.
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit